Skip to content

Press Releases and Events

Press Releases

Filter Releases
Press Releases and Events
Date Title and Summary View
Dec 20, 2007
Intra-Cellular Therapies, Inc. (ITI), today announced it has initiated a sleep maintenance insomnia (SMI) Phase 2 clinical study using its drug candidate ITI-722. ITI-722 acts predominantly as a selective 5-HT2A receptor antagonist and represents an important new approach to the treatment of SMI. Because of its novel separation of 5-HT2A and dop...
Dec 19, 2007
Intra-Cellular Therapies, Inc. (ITI) presented preclinical data on ITI-007, its first in class dual 5HT 2A receptor antagonist/dopamine receptor phosphoprotein modulator (DPPM) at a major medical meeting last week. The Company is developing ITI-007 for the treatment of schizophrenia and other related psychiatric conditions. In this p...
Sep 18, 2007
Intra-Cellular Therapies today announced it has developed a novel series of non-hormonal compounds that show promise in the treatment of female sexual dysfunction (FSD). These small molecule agents are specific and potent inhibitors designed to regulate neuronal activity in selected regions of the brain. The Company believes these compounds may ...
Jun 21, 2007
NEW YORK, NY, JUNE 21, 2007 -- Intra-Cellular Therapies, Inc., today announced it has initiated Phase I clinical trials for ITI-007, the Company's first-in-class dual 5HT2A receptor antagonist/dopamine receptor phosphoprotein modulator (DPPM) for the treatment of schizophrenia, and ITI-722, a low dose formulation of ITI-007 with selective 5HT2A ...
Jun 1, 2005
Intra-Cellular Therapies, Inc., (ITI) a privately held biopharmaceutical company focusing on the development of new therapeutics for neuropsychiatric and neurodegenerative disorders, today announced that it has been granted an exclusive, worldwide license to a family of pre-clinical compounds from Bristol-Myers Squibb Company (NYSE: BMY). ...
Page: First Previous
= add release to Briefcase

Upcoming Events

Details on upcoming events are not yet available. Please click here to be notified of all upcoming events.